1. Purpose
To define the procedure for obtaining marketing authorization for medicinal products in the UK, ensuring compliance with applicable laws and regulations.
2. Scope
This SOP applies to all pharmaceutical organizations and teams involved in the registration and submission of medicinal products for approval by the MHRA.
3. Definitions and Abbreviations
- MHRA: Medicines and Healthcare products Regulatory Agency.
- Marketing Authorization (MA): Permission to market a medicinal product in the UK.
- Common Technical Document (CTD): Standardized format for submitting product dossiers.
- PL Number: Product License number issued upon successful registration.
4. Responsibilities
Regulatory Affairs Team:
1. Regulatory Intelligence and Strategy Development
The RA team is responsible for staying updated with the latest regulations, guidelines, and directives issued by the MHRA and other relevant authorities.
Key Tasks:
- Monitoring Regulatory Changes: Keeping abreast of updates in MHRA policies, UK-specific requirements, and global standards.
- Strategic Planning: Developing a robust regulatory strategy tailored to the product type, ensuring compliance without delays.
- Precedent Analysis: Reviewing previously approved similar products to guide dossier preparation and submissions.
2. Dossier Compilation and Submission
Preparing and submitting the dossier is one of the RA team’s primary responsibilities. They ensure the completeness and accuracy of the Common Technical Document (CTD) for submission.
Key Tasks:
- Assembling CTD Modules: Compiling administrative, quality, non-clinical, and clinical data (Modules 1-5).
- Ensuring Data Integrity: Cross-verifying all data for accuracy, consistency, and compliance with MHRA requirements.
- Electronic Submissions: Converting the dossier into eCTD format and uploading it via the MHRA Portal or Submissions Delivery Service.
3. Compliance with Manufacturing Standards
Ensuring the product and manufacturing site adhere to Good Manufacturing Practice (GMP) standards is a critical responsibility.
Key Tasks:
- Active Substance Master File (ASMF): Managing the submission of ASMFs for products involving active pharmaceutical ingredients.
- Quality Documentation: Collaborating with the Quality Assurance team to include detailed specifications, stability data, and validation reports in the dossier.
4. Interaction with Regulatory Authorities
Effective communication with the MHRA is crucial for a smooth registration process.
Key Tasks:
- Scientific Advice Meetings: Organizing pre-submission meetings with the MHRA to clarify regulatory expectations.
- Query Resolution: Responding to MHRA inquiries during the validation and assessment phases promptly and accurately.
- Liaison Role: Acting as the primary point of contact between the company and regulatory bodies.
5. Labeling and Product Information Management
The RA team ensures all product-related documentation aligns with MHRA requirements and is accessible to healthcare professionals and consumers.
Key Tasks:
- Summary of Product Characteristics (SmPC): Drafting the SmPC to provide accurate product information.
- Patient Information Leaflets (PIL): Ensuring PILs are clear, user-friendly, and compliant with regulatory standards.
- Artwork Review: Approving labeling and packaging materials to meet regulatory specifications.
6. Risk Management and Pharmacovigilance
The RA team plays an essential role in ensuring post-marketing safety and compliance.
Key Tasks:
- Risk Management Plans (RMP): Preparing and submitting RMPs as part of the dossier.
- Pharmacovigilance Systems: Establishing systems for monitoring adverse effects and ensuring timely reporting.
- Post-Marketing Surveillance: Collaborating with pharmacovigilance teams to meet periodic safety update report (PSUR) obligations.
7. Fee and Timelines Management
Managing fees and adhering to strict timelines are essential to avoid delays in the registration process.
Key Tasks:
- Fee Payment: Ensuring timely payment of MHRA application fees.
- Timeline Tracking: Monitoring regulatory timelines and flagging potential delays.
8. Training and Support for Cross-Functional Teams
The RA team also supports internal teams by providing regulatory insights and training.
Key Tasks:
- Regulatory Training: Educating other departments about MHRA requirements and compliance measures.
- Cross-Departmental Collaboration: Coordinating with R&D, Quality Assurance, and Marketing teams to align efforts.
9. Post-Authorization Maintenance
The RA team’s responsibilities extend beyond registration, ensuring continued compliance throughout the product’s lifecycle.
Key Tasks:
- Variation Applications: Managing changes to the product, such as updates to manufacturing processes or labeling.
- Renewals: Submitting applications for marketing authorization renewal within required timelines.
- Regulatory Updates: Ensuring any new requirements are met post-authorization.
10. Record-Keeping and Documentation
Maintaining thorough records is vital for audits and future submissions.
Key Tasks:
- Archiving Submissions: Storing copies of all submitted documents securely.
- Audit Preparation: Ensuring records are readily available for internal and external audits.
Quality Assurance Team:
1. Ensuring Compliance with GMP Standards
Compliance with Good Manufacturing Practice (GMP) is a fundamental requirement for product registration. The QA team ensures that all manufacturing processes adhere to these standards.
Key Responsibilities:
- Manufacturing Site Audits: Conducting internal and external audits of manufacturing facilities to verify GMP compliance.
- Standard Operating Procedures (SOPs): Developing and maintaining SOPs for manufacturing processes to ensure consistency and quality.
- Corrective and Preventive Actions (CAPAs): Addressing any identified non-compliances or deviations through structured CAPA plans.
2. Preparation of Quality Documentation for the Dossier
The QA team is responsible for providing comprehensive and accurate quality data for inclusion in the Common Technical Document (CTD) submitted to the MHRA.
Key Responsibilities:
- Specifications and Testing: Ensuring detailed specifications and test results for active ingredients, excipients, and finished products are documented.
- Batch Records: Providing records of batch production and testing to demonstrate reproducibility and quality.
- Validation Reports: Compiling process validation, cleaning validation, and analytical method validation reports.
- Stability Data: Preparing stability study reports to confirm product shelf life under recommended storage conditions.
3. Coordination with Regulatory Affairs Team
The QA team collaborates closely with the Regulatory Affairs (RA) team to ensure that all quality-related aspects of the dossier meet regulatory expectations.
Key Responsibilities:
- Data Review: Reviewing quality sections of the CTD for accuracy and completeness before submission.
- Addressing Queries: Assisting the RA team in responding to MHRA queries related to quality data during the assessment phase.
4. Supplier and Vendor Qualification
The QA team ensures that all raw materials and components used in manufacturing meet quality standards by qualifying suppliers and vendors.
Key Responsibilities:
- Supplier Audits: Conducting audits of raw material and component suppliers to verify GMP compliance.
- Certificate of Analysis (CoA): Reviewing CoAs to confirm the quality of incoming materials.
- Quality Agreements: Establishing agreements with suppliers to define quality expectations and responsibilities.
5. Risk Management
The QA team identifies and mitigates risks associated with product quality, ensuring safety and compliance.
Key Responsibilities:
- Risk Assessments: Performing quality risk assessments for manufacturing processes and materials.
- Failure Mode and Effects Analysis (FMEA): Identifying potential failure points and implementing preventive measures.
6. Quality Control of Packaging and Labeling
The QA team verifies that packaging and labeling materials comply with MHRA guidelines and ensure accurate representation of the product.
Key Responsibilities:
- Artwork Review: Reviewing and approving labeling and packaging artwork for accuracy and regulatory compliance.
- Tamper-Evident Packaging: Ensuring packaging meets safety requirements to prevent tampering.
7. Post-Marketing Quality Assurance
Even after a product is registered and marketed, the QA team continues to monitor and ensure product quality.
Key Responsibilities:
- Change Control: Managing changes in manufacturing processes or suppliers that could impact product quality.
- Complaints Handling: Investigating and resolving complaints related to product quality.
- Product Recalls: Coordinating recall procedures if quality issues are identified post-market.
8. Training and Development
The QA team ensures that all personnel involved in manufacturing and quality control are trained in GMP and regulatory requirements.
Key Responsibilities:
- GMP Training: Conducting regular training sessions on GMP principles and updates.
- Competency Assessments: Evaluating staff proficiency in quality-related tasks and addressing gaps.
9. Record-Keeping and Documentation
Maintaining detailed records is essential for regulatory compliance and audits.
Key Responsibilities:
- Document Control: Managing versions of quality documents to ensure only current versions are in use.
- Audit Trails: Maintaining an accessible record of quality audits, CAPAs, and risk assessments.
- Archiving: Storing historical quality data for future reference and regulatory inspections.
10. Contribution to Regulatory Audits and Inspections
The QA team plays a critical role during regulatory audits conducted by the MHRA or other authorities.
Key Responsibilities:
- Audit Preparation: Ensuring all quality records and data are readily available and up-to-date.
- On-Site Support: Addressing questions from inspectors and providing necessary documentation during audits.
- Post-Audit Actions: Implementing corrective actions based on audit findings and recommendations.
Pharmacovigilance Team:
1. Establishing a Pharmacovigilance System
The PV team must develop and maintain a robust pharmacovigilance system to monitor product safety.
Key Responsibilities:
- Risk Management Systems: Setting up systems to identify, evaluate, and mitigate risks associated with the product.
- Qualified Person for Pharmacovigilance (QPPV): Ensuring a QPPV is appointed and accessible to oversee all PV activities.
- Standard Operating Procedures (SOPs): Developing SOPs for adverse event reporting, signal detection, and risk mitigation.
2. Compilation of the Pharmacovigilance System Master File (PSMF)
The PSMF is a mandatory document in the registration process, detailing the PV system and activities.
Key Responsibilities:
- Document Preparation: Preparing and maintaining the PSMF, ensuring it includes all required information such as QPPV details, organizational structure, and adverse event reporting processes.
- Regulatory Submission: Submitting the PSMF as part of the marketing authorization application to the MHRA.
- Regular Updates: Ensuring the PSMF is current and reflects any changes in the PV system.
3. Risk Management Planning
The PV team is responsible for creating and implementing a Risk Management Plan (RMP) as part of the medicinal product registration process.
Key Responsibilities:
- Risk Identification: Assessing potential risks based on preclinical and clinical data.
- RMP Preparation: Developing a comprehensive RMP outlining the safety concerns, proposed risk minimization measures, and monitoring strategies.
- Submission and Updates: Submitting the RMP to the MHRA and updating it based on new safety information.
4. Adverse Event Monitoring and Reporting
Monitoring adverse events (AEs) and ensuring their timely reporting to regulatory authorities is a core function of the PV team.
Key Responsibilities:
- Data Collection: Collecting data on adverse events from clinical trials, healthcare professionals, and post-marketing surveillance.
- Regulatory Reporting: Submitting individual case safety reports (ICSRs) and periodic safety update reports (PSURs) to the MHRA.
- Compliance with Timelines: Ensuring serious adverse event reports are submitted within 15 calendar days and non-serious reports within the required timeframes.
5. Signal Detection and Management
The PV team monitors safety data to identify potential safety signals and address them proactively.
Key Responsibilities:
- Data Analysis: Reviewing adverse event data for trends or patterns that suggest emerging risks.
- Signal Assessment: Evaluating signals to determine their impact on the product’s benefit-risk profile.
- Risk Communication: Communicating signals to regulatory authorities and updating labeling or risk management measures accordingly.
6. Post-Marketing Safety Surveillance
Once a medicinal product is registered, the PV team continues to monitor its safety in real-world use.
Key Responsibilities:
- Periodic Safety Update Reports (PSURs): Preparing and submitting PSURs to provide a comprehensive safety overview.
- Real-World Evidence Collection: Gathering safety data from post-marketing studies, observational research, and spontaneous reporting systems.
- Risk Minimization Activities: Implementing additional measures, such as educational materials for healthcare professionals and patients.
7. Labeling and Product Information Updates
Ensuring that safety-related information on the product label and patient information leaflet (PIL) is accurate and up-to-date.
Key Responsibilities:
- Safety Updates: Revising the Summary of Product Characteristics (SmPC) and PIL based on new safety information.
- Regulatory Submission: Submitting labeling changes to the MHRA for approval.
- Communication: Ensuring timely dissemination of updated safety information to stakeholders.
8. Collaboration with Other Teams
The PV team works closely with other departments to ensure a seamless registration process.
Key Responsibilities:
- Clinical Teams: Collaborating to collect safety data from clinical trials.
- Regulatory Affairs: Providing safety-related documents, such as the RMP and PSMF, for the marketing authorization application.
- Quality Assurance: Addressing any quality issues that could impact product safety.
9. Responding to Regulatory Inquiries
The PV team plays a crucial role in addressing safety-related questions from the MHRA during the product registration process.
Key Responsibilities:
- Data Submission: Providing additional safety data or clarifications as requested by the MHRA.
- Proactive Communication: Keeping the MHRA informed of any emerging safety concerns during the review process.
10. Training and Awareness
The PV team ensures that all relevant stakeholders are trained on pharmacovigilance requirements and practices.
Key Responsibilities:
- Staff Training: Conducting training sessions for internal teams on adverse event reporting and safety monitoring.
- Stakeholder Engagement: Educating healthcare professionals and patients about the importance of reporting adverse events.
5. Required Documents
- Administrative Information:
- Cover letter.
- Application form (eCTD format recommended).
- Quality Data:
- Detailed specifications, manufacturing processes, and controls.
- Stability studies and batch analysis results.
- Non-Clinical Data:
- Toxicology and pharmacology studies.
- Clinical Data:
- Clinical trial results demonstrating safety and efficacy.
- Risk Management Plan (RMP).
- Product Information:
- Summary of Product Characteristics (SmPC).
- Package leaflet and labeling information.
6. Procedure
6.1. Preliminary Activities
- Identify the Registration Pathway:
- Determine the appropriate route: national, decentralized, mutual recognition, or centralized procedure.
- For UK-specific approval, use the national pathway managed by the MHRA.
- Compile Regulatory Intelligence:
- Review MHRA guidelines and requirements for the type of product.
- Analyze precedents from similar products where applicable.
- Engage with MHRA:
- Request a scientific advice meeting if necessary to clarify regulatory expectations.
6.2. Application Preparation
- Compile the Dossier:
- Assemble the application in the CTD format, including Modules 1 to 5.
- Ensure data integrity and completeness.
- Validate Product-Specific Requirements:
- Check compliance with Good Manufacturing Practice (GMP) for the manufacturing site.
- Include an Active Substance Master File (ASMF) if applicable.
- Digital Submission:
- Convert the dossier into electronic format (eCTD).
6.3. Submission to MHRA
- Register for Submission Portal Access:
- Use the MHRA Portal or the Submissions Delivery Service.
- Submit Application:
- Upload the dossier and pay the applicable fees.
- Acknowledge Receipt:
- Confirm receipt of submission via acknowledgment from MHRA.
6.4. MHRA Assessment
- Validation Phase:
- MHRA reviews the dossier for completeness within 14 days of submission.
- Address validation queries promptly if raised.
- Assessment Phase:
- Two phases of review (clinical and non-clinical data, followed by risk-benefit evaluation).
- Respond to additional information requests (clock-stop periods may apply).
6.5. Decision and Post-Approval Steps
- Grant of Marketing Authorization:
- MHRA issues a PL number upon approval.
- Publication of Product Information:
- Ensure SmPC and other product details are published on the MHRA database.
- Post-Marketing Obligations:
- Implement pharmacovigilance systems.
- Fulfill periodic safety update report (PSUR) requirements.
7. Training
- All personnel involved in product registration must undergo training in MHRA submission guidelines and eCTD software.
8. Quality Control
- Conduct periodic audits of registration processes to ensure compliance and identify areas for improvement.
9. References
- MHRA Guidance for Licensing Medicines.
- European Medicines Agency (EMA) Guidelines for CTD Dossier Preparation.
- Good Manufacturing Practices (GMP) Regulations.
10. Revision History
| Version | Date | Changes Made | Approved By |
|---|---|---|---|
| 1.0 | YYYY-MM-DD | Initial SOP | [Name] |
| 1.1 | YYYY-MM-DD | Updated Procedures | [Name] |
For more articles, Kindly Click here.
For pharmaceutical jobs, follow us on LinkedIn
For Editable SOPs in Word format contact us on info@pharmaceuticalcarrier.com
For more information kindly follow us on www.pharmaguidelines.co.uk
